Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

HARRY W KUBERG

Allopathic & Osteopathic Physicians Family Medicine

NPI
1760537633
CMS profile
125652
Location
RUSSELLVILLE, AL

General Payments · PY2018–2024

$12,743.31

  • Reported across 559 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$665.17

31 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $665.17 31

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
ABBVIE INC. $249.58 15
Phathom Pharmaceuticals, Inc. $209.45 4
Acerta Pharma LLC $43.43 3
Novo Nordisk AS $38.26 2
Bayer HealthCare Pharmaceuticals Inc. $29.50 2
Merck Sharp & Dohme Corporation $22.06 1
GlaxoSmithKline, LLC. $20.76 1
Amgen Inc. $18.86 1
PFIZER INC. $16.86 1
Lilly USA, LLC $16.41 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $2,901.46 132
PY2019 $2,536.71 100
PY2020 $2,063.37 102
PY2021 $2,394.69 120
PY2022 $1,393.06 40
PY2023 $788.85 34
PY2024 $665.17 31

Payment records · PY2024 (31)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $14.37 02/07/2024 Food and Beverage Undisputed 01/23/2026 1104113126 CMS
ABBVIE INC. $17.02 03/05/2024 Food and Beverage Undisputed 01/23/2026 1104113128 CMS
ABBVIE INC. $2.28 03/18/2024 Food and Beverage Undisputed 01/23/2026 1104113130 CMS
ABBVIE INC. $9.11 04/09/2024 Food and Beverage Undisputed 01/23/2026 1104113132 CMS
ABBVIE INC. $19.75 04/30/2024 Food and Beverage Undisputed 01/23/2026 1104113134 CMS
ABBVIE INC. $4.28 05/20/2024 Food and Beverage Undisputed 01/23/2026 1104113136 CMS
ABBVIE INC. $20.52 05/28/2024 Food and Beverage Undisputed 01/23/2026 1104113138 CMS
ABBVIE INC. $97.36 06/06/2024 Food and Beverage Undisputed 01/23/2026 1104113140 CMS
ABBVIE INC. $3.17 06/10/2024 Food and Beverage Undisputed 01/23/2026 1104113142 CMS
ABBVIE INC. $9.31 07/11/2024 Food and Beverage Undisputed 01/23/2026 1104113144 CMS
ABBVIE INC. $19.36 07/24/2024 Food and Beverage Undisputed 01/23/2026 1104113146 CMS
ABBVIE INC. $15.19 09/09/2024 Food and Beverage Undisputed 01/23/2026 1104113148 CMS
ABBVIE INC. $3.47 10/15/2024 Food and Beverage Undisputed 01/23/2026 1104113150 CMS
ABBVIE INC. $4.70 11/07/2024 Food and Beverage Undisputed 01/23/2026 1104113152 CMS
ABBVIE INC. $9.69 11/07/2024 Food and Beverage Undisputed 01/23/2026 1104113154 CMS
Amgen Inc. $18.86 06/18/2024 Food and Beverage Undisputed 01/23/2026 1117302389 CMS
AstraZeneca Pharmaceuticals LP $14.55 01/24/2024 Food and Beverage Undisputed 01/23/2026 1105826185 CMS
AstraZeneca Pharmaceuticals LP $13.83 04/03/2024 Food and Beverage Undisputed 01/23/2026 1105789946 CMS
AstraZeneca Pharmaceuticals LP $15.05 09/04/2024 Food and Beverage Undisputed 01/23/2026 1105855870 CMS
Bayer Healthcare Pharmaceuticals Inc. $14.60 01/29/2024 Food and Beverage Undisputed 01/23/2026 1086123362 CMS
Bayer Healthcare Pharmaceuticals Inc. $14.90 03/27/2024 Food and Beverage Undisputed 01/23/2026 1086183456 CMS
GlaxoSmithKline, LLC. $20.76 04/16/2024 Food and Beverage Undisputed 01/23/2026 1116311473 CMS
Lilly USA, LLC $16.41 06/14/2024 Food and Beverage Undisputed 01/23/2026 1134997060 CMS
Merck Sharp & Dohme LLC $22.06 05/30/2024 Food and Beverage Undisputed 01/23/2026 1141863057 CMS
Novo Nordisk Inc $19.25 04/01/2024 Food and Beverage Undisputed 01/23/2026 1096760033 CMS
Novo Nordisk Inc $19.01 08/06/2024 Food and Beverage Undisputed 01/23/2026 1097674325 CMS
PFIZER INC. $16.86 09/05/2024 Food and Beverage Undisputed 01/23/2026 1131872525 CMS
Phathom Pharmaceuticals, Inc. $11.59 03/11/2024 Food and Beverage Undisputed 01/23/2026 1151084719 CMS
Phathom Pharmaceuticals, Inc. $96.10 03/19/2024 Food and Beverage Undisputed 01/23/2026 1151084721 CMS
Phathom Pharmaceuticals, Inc. $3.64 04/17/2024 Food and Beverage Undisputed 01/23/2026 1151084723 CMS
Phathom Pharmaceuticals, Inc. $98.12 08/07/2024 Food and Beverage Undisputed 01/23/2026 1151084725 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.